Helsingin Yliopisto

Helsinki, Uusimaa

UEI
YM1UNKPWTJL9
CAGE
A260G
Primary NAICS
611310 Colleges, Universities, and Professional Schools
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
  • Educational Institution
  • State Controlled Institution of Higher Learning
Entity structure
Other
SAM.gov registration date
Physical address
Fabianinkatu 33, 00100 Helsinki, Finland
Website
helsinki.fi
Employees
5K-10K
Estimated annual revenue
$1B-$10B
Industry
  1. Consumer Discretionary
  2. Diversified Consumer Services
  3. Education Services
  4. Education
SIC code
82 Educational Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
This acquisition is to procure single cell RNA SEQ services 75N92021P00073 National Heart Lung and Blood Institute (NIH) $34,846
Professional service order for DR. Mart saarma, university of helsinki institute of biotechnology, university of… HHSN271200900487P National Institute on Drug Abuse (NIH) $50,000
Recombinant manf neurotrophic factor protein:2MG; more than 95% pure (manf full length cdna in an expression vector… HHSN271200700315P National Institute on Drug Abuse (NIH) $90,000

Grant awards

Award Agency Obligated Awarded
Novel mitochondrial metabolism inhibitors for aggressive and treatment-resistant MYC-high breast cancers HT9425261E167 Defense Health Agency $879,495
R & d, science and engineering, in the area of electrical FA86552317057 Air Forces Europe and Africa (USAF) $225,000
R & d, science and engineering, in the area of physics FA86552217037 Air Forces Europe and Africa (USAF) $166,966
Single-cell crispra screen to identify transcription factors that mediate neuroblastoma phenotypic switching and… W81XWH2110773 Defense Health Agency $2,115,300
Capturing large-scale locus coeruleus single neuron activity in behaving rats with nanoelectronic threads (nets), an… R34NS123876 National Institute of Neurological Disorders and Stroke (NIH) $1,386,072

Latest 5 listed here. See the rest on GovTribe.

Grant subawards

Prime recipient Prime award Amount Awarded
Institute For Systems Biology Support the development and validation of an acute myeloid leukemia (AML) digital twin prototype to predict treatment response and advance personalized… R01CA270210 $72,373
Institute For Systems Biology For more than a decade Dr. Caroline Heckman and her group have performed translational research studies on AML with the aim to improve and personalize AML… R01CA270210 $80,528
The Johns Hopkins University Rapireon, a new macrocycle molecular glue that selectively activates the nuclease activity of IRE1 RF1NS138343 $708,319
The General Hospital Corporation We will use the results produced by the FinnGen project. The FinnGen sample consists of longitudinal health register data and associated genomics information… RF1MH134638 $37,286
Oregon State University Modulation of Protein Biogenesis and Scretion by Natural Product Translocon Ligands R01GM132649 $24,921

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

Vendor Location Primary NAICS
Universitetet I Oslo UEI D2HNZH1A2KC8 Oslo —
Oulun Yliopisto UEI HUF2M24KQD46 Oulu 611310 Colleges, Universities, and Professional Schools
Monash University UEI W2VLWNVNL728 VIC 611310 Colleges, Universities, and Professional Schools
Accounting UEI NNJ6BMBTFGN5 San Diego, CA 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
The Rockefeller University UEI LHGDNJMZ64Y1 New York, NY 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Helsingin Yliopisto (University of Helsinki), a Finnish state-controlled non-profit research institution headquartered in Helsinki, acts as a prime recipient of federal research grants and as a sub-recipient on collaborative biomedical and life-sciences projects sponsored by U.S. federal agencies. The university does not hold federal contracts or contract vehicles; its federal footprint consists entirely of research grants under the National Institutes of Health and the Department of Defense.

The University of Helsinki operates in basic and translational biomedical research, with capability concentration in oncology, systems neuroscience, genomics, and semiconductor physics. Prime grant work includes a $879,495 three-year project grant from the Defense Health Agency (CFDA 12.420, Military Medical Research and Development) awarded June 1, 2026, supporting research into novel mitochondrial metabolism inhibitors targeting aggressive and treatment-resistant MYC-high breast cancers; a research project from the Air Force on point defects and electrical compensation in ultrawide-bandgap semiconductors (award date August 15, 2023, completion August 14, 2026); and an NINDS (National Institute of Neurological Disorders and Stroke) grant awarded August 15, 2021 (completion July 31, 2025) for capturing large-scale locus coeruleus single neuron activity in behaving rats using nanoelectronic threads. The university also holds a prior Air Force project grant on equilibrium and non-equilibrium point defects in SiGeSn alloys (August 1, 2022 to July 31, 2025) and a Defense Health Agency grant on single-cell CRISPR screening and MYC synthetic lethality for metastatic breast cancer (September 1, 2021 to September 14, 2026).

Customer concentration across federal agencies is diffuse; the top five customer NIH institutes and the Air Force together account for 38% of recent awards by count, with NIH centers (National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institute of General Medical Sciences, and National Heart Lung and Blood Institute) dominating the portfolio. The university serves 16 distinct federal agencies across recent awards. In sub-recipient roles, the university participates in grant subawards from prime grantees including the Institute for Systems Biology (acute myeloid leukemia digital twin and drug sensitivity research, May 2025 and May 2024), Johns Hopkins University (molecular glue activation research, January 2025), Massachusetts General Hospital (Long COVID and chronic fatigue syndrome genetic analysis, July 2023), University of Southern California (education and cognitive decline genetics, January 2023), Oregon State University (protein biogenesis and secretion, June and September 2024), and University of South Florida (pediatric diabetes determinants, April 2024). Recent activity is modest — one to five awards per year in the 2023–2025 period — with two awards reaching ultimate completion within the next twenty-four months.

Quick answers

Is Helsingin Yliopisto registered in SAM.gov?

Yes. Helsingin Yliopisto's SAM.gov registration is active through April 2, 2027.

What is Helsingin Yliopisto's most recent federal award?

Helsingin Yliopisto's most recent federal grant award is Novel mitochondrial metabolism inhibitors for aggressive and treatment-resistant MYC-high breast cancers (HT9425261E167), from Defense Health Agency, on June 1, 2026.

On GovTribe

See Helsingin Yliopisto's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login